Claiborne Cary J Insider Trades

Insider Trading History

Track insider trading activity for Claiborne Cary J. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Adial Pharmaceuticals- Warrants (31/07/2023)
Adial Pharmaceuticals- Warrants (31/07/2023) ADILW
Chief Executive Officer
Holding Value $36.4 40,417 shares
Last Trade
Apr 07, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$34.2 37,985 shares
$0.00
$0.00
Adial Pharmaceuticals
Adial Pharmaceuticals ADIL
Chief Executive Officer
Holding Value $97.8k 40,417 shares
Last Trade
Apr 07, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$62.3k 37,985 shares
$1.64
$2.42
Adial Pharmaceuticals- Warrants (31/07/2023)
Adial Pharmaceuticals- Warrants (31/07/2023) ADILW
Chief Executive Officer
Holding Value $124 138,000 shares
Last Trade
May 29, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$124 138,000 shares
$0.00
$0.00
Adial Pharmaceuticals
Adial Pharmaceuticals ADIL
Chief Executive Officer
Holding Value $334k 138,000 shares
Last Trade
May 29, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$95.2k 138,000 shares
$0.69
$2.42
Adial Pharmaceuticals- Warrants (31/07/2023)
Adial Pharmaceuticals- Warrants (31/07/2023) ADILW
Chief Executive Officer
Holding Value $315 350,000 shares
Last Trade
Dec 05, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$315 350,000 shares
$0.00
$0.00
Adial Pharmaceuticals
Adial Pharmaceuticals ADIL
Chief Executive Officer
Holding Value $847k 350,000 shares
Last Trade
Dec 05, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$403k 350,000 shares
$1.15
$2.42
Adial Pharmaceuticals
Adial Pharmaceuticals ADIL
Chief Executive Officer
Holding Value $145k 60,000 shares
Last Trade
Mar 25, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$81k 60,000 shares
$1.35
$2.42
Adial Pharmaceuticals- Warrants (31/07/2023)
Adial Pharmaceuticals- Warrants (31/07/2023) ADILW
Chief Executive Officer
Holding Value $54 60,000 shares
Last Trade
Mar 25, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$54 60,000 shares
$0.00
$0.00
Adial Pharmaceuticals
Adial Pharmaceuticals ADIL
Chief Executive Officer
Holding Value $3.68M 1,520,000 shares
Last Trade
May 23, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$90k 300,000 shares
$0.30
$2.42
Adial Pharmaceuticals- Warrants (31/07/2023)
Adial Pharmaceuticals- Warrants (31/07/2023) ADILW
Chief Executive Officer
Holding Value $1.37k 1,520,000 shares
Last Trade
May 23, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.7k 300,000 shares
$0.01
$0.00
NeuroSense Therapeutics
NeuroSense Therapeutics NRSN
Director
Holding Value $0 0 shares
Last Trade
Mar 10, 2023 Sale
$123k 72,000 shares
$1.71
$0.78
NeuroSense Therapeutics Ltd - Warrants (09/11/2026)
NeuroSense Therapeutics Ltd - Warrants (09/11/2026) NRSNW
Director
Holding Value $0 0 shares
Last Trade
Mar 10, 2023 Sale
$29.5k 72,000 shares
$0.41
$0.19
Adial Pharmaceuticals
Adial Pharmaceuticals ADIL
Chief Executive Officer
Holding Value $2.66M 1,100,000 shares
Last Trade
Sep 20, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$31.5k 75,000 shares
$0.42
$2.42
Adial Pharmaceuticals- Warrants (31/07/2023)
Adial Pharmaceuticals- Warrants (31/07/2023) ADILW
Chief Executive Officer
Holding Value $990 1,100,000 shares
Last Trade
Sep 20, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.58k 75,000 shares
$0.06
$0.00
Adial Pharmaceuticals- Warrants (31/07/2023)
Adial Pharmaceuticals- Warrants (31/07/2023) ADILW
Chief Executive Officer
Holding Value $923 1,025,000 shares
Last Trade
Sep 19, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.53k 25,000 shares
$0.06
$0.00
Adial Pharmaceuticals
Adial Pharmaceuticals ADIL
Chief Executive Officer
Holding Value $2.48M 1,025,000 shares
Last Trade
Sep 19, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$10.8k 25,000 shares
$0.43
$2.42
Adial Pharmaceuticals- Warrants (31/07/2023)
Adial Pharmaceuticals- Warrants (31/07/2023) ADILW
Chief Executive Officer
Holding Value $900 1,000,000 shares
Last Trade
Aug 18, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$65k 1,000,000 shares
$0.06
$0.00
Adial Pharmaceuticals
Adial Pharmaceuticals ADIL
Chief Executive Officer
Holding Value $2.42M 1,000,000 shares
Last Trade
Aug 18, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$590k 1,000,000 shares
$0.59
$2.42
Adial Pharmaceuticals
Adial Pharmaceuticals ADIL
Chief Operating Officer
Holding Value $16.1k 6,667 shares
Last Trade
Feb 23, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$13.3k 6,667 shares
$2.00
$2.42
Adial Pharmaceuticals- Warrants (31/07/2023)
Adial Pharmaceuticals- Warrants (31/07/2023) ADILW
Chief Operating Officer
Holding Value $6 6,667 shares
Last Trade
Feb 23, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.47k 6,667 shares
$0.67
$0.00

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up